4.5 Review

Glutathione S-Transferase M1/T1 Polymorphisms and Schizophrenia Risk: A New Method for Quality Assessment and a Systematic Review

Related references

Note: Only part of the references are listed.
Article Psychiatry

Additive effect of glutathione S-transferase T1 active genotype and infection with Toxoplasma gondii for increasing the risk of schizophrenia

Maryam Ansari-Lari et al.

Summary: The study findings suggest an additive effect of Toxoplasma gondii infection and GSTT1 active genotype as risk factors for schizophrenia in the Iranian population. Replicating the study with larger groups of patients in multinational investigations is recommended to clarify these findings.

NORDIC JOURNAL OF PSYCHIATRY (2021)

Review Cell Biology

Oxidative Stress-Related Mechanisms in Schizophrenia Pathogenesis and New Treatment Perspectives

Evgeny A. Ermakov et al.

Summary: Schizophrenia is a highly heterogeneous disease at various levels, with oxidative stress-related mechanisms playing a significant role in its manifestation and development, involving genetic causes, mitochondrial dysfunction, metabolic abnormalities, and more. These mechanisms ultimately contribute to the occurrence and progression of schizophrenia at the whole-organism level.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2021)

Review Psychology, Clinical

Genetic architecture of schizophrenia: a review of major advancements

Sophie E. Legge et al.

Summary: Schizophrenia is a severe psychiatric disorder with high heritability. Recent research has identified numerous genetic loci associated with the disorder, with genome-wide association studies revealing 176 distinct genetic loci and ongoing studies indicating a total of 270 common genetic loci. Polygenic risk scores can explain a portion of the variance in schizophrenia, and rare variant studies have highlighted specific genetic variants linked to an increased risk of schizophrenia. Gene-set analyses have also shown enrichment of genetic variants related to schizophrenia in synaptic pathways, pointing towards potential new avenues for research and treatment.

PSYCHOLOGICAL MEDICINE (2021)

Article Psychiatry

Oxidative stress biomarkers in treatment-responsive and treatment-resistant schizophrenia patients

Patrick Buosi et al.

Summary: Schizophrenia patients show lower SOD levels and higher MDA and CAT levels, indicating oxidative damage. Smoking and family history of the disease are correlated with schizophrenia cases, highlighting the relevance of genetics in disease development.

TRENDS IN PSYCHIATRY AND PSYCHOTHERAPY (2021)

Article Biochemistry & Molecular Biology

Schizophrenia-associated genomic copy number variants and subcortical brain volumes in the UK Biobank

Anthony Warland et al.

MOLECULAR PSYCHIATRY (2020)

Article Clinical Neurology

Association Between Glutathione S-Transferase (GST) Polymorphisms and Schizophrenia in a Chinese Han Population

Ci Yan et al.

NEUROPSYCHIATRIC DISEASE AND TREATMENT (2020)

Article Biochemistry & Molecular Biology

Glutathione S-transferases promote proinflammatory astrocyte-microglia communication during brain inflammation

Shin-ichi Kano et al.

SCIENCE SIGNALING (2019)

Article Psychiatry

Validation of oxidative stress assay for schizophrenia

Eunkyoung Kim et al.

SCHIZOPHRENIA RESEARCH (2019)

Article Oncology

Polymorphisms of GSTM1, GSTT1, GSTP1 genes and chromosomal aberrations in lung cancer patients

Varvara I. Minina et al.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2017)

Article Medical Laboratory Technology

Glutathione S-Transferase Deletion Polymorphisms in Early-Onset Psychotic and Bipolar Disorders: A Case-Control Study

Milica M. Pejovic-Milovancevic et al.

LABORATORY MEDICINE (2016)

Article Medical Laboratory Technology

Glutathione S-Transferase Deletion Polymorphisms in Early-Onset Psychotic and Bipolar Disorders: A Case-Control Study

Milica M. Pejovic-Milovancevic et al.

LABORATORY MEDICINE (2016)

Review Biochemistry & Molecular Biology

Genetic Polymorphisms of Glutathione-Related Enzymes (GSTM1, GSTT1, and GSTP1) and Schizophrenia Risk: A Meta-Analysis

Su Kang Kim et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)

Article Neurosciences

Cell type- and brain region-resolved mouse brain proteome

Kirti Sharma et al.

NATURE NEUROSCIENCE (2015)

Article Pharmacology & Pharmacy

Association of Glutathione S-Transferase Gene Methylation with Risk of Schizophrenia in an Iranian Population

Dor Mohammad Kordi-Tamandani et al.

PHARMACOLOGY (2014)

Article Biochemistry & Molecular Biology

Naturally Occurring Variation in the Glutathione-S-Transferase 4 Gene Determines Neurodegeneration After Traumatic Brain Injury

Faiez Al Nimer et al.

ANTIOXIDANTS & REDOX SIGNALING (2013)

Article Clinical Neurology

Possible associations between antioxidant enzyme polymorphisms and metabolic abnormalities in patients with schizophrenia

Junji Saruwatari et al.

NEUROPSYCHIATRIC DISEASE AND TREATMENT (2013)

Review Biochemistry & Molecular Biology

Genetic Association Studies of Antioxidant Pathway Genes and Schizophrenia

Kodavali V. Chowdari et al.

ANTIOXIDANTS & REDOX SIGNALING (2011)

Article Genetics & Heredity

Association Study Between the Genetic Polymorphisms of Glutathione-Related Enzymes and Schizophrenia in a Japanese Population

Daisuke Matsuzawa et al.

AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2009)

Article Pharmacology & Pharmacy

Glutathione S-transferase M1 and T1 null genotype distribution in South Indians

AT Naveen et al.

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2004)

Article Biochemistry & Molecular Biology

Glutathione S-transferase M1 gene deletion may be associated with susceptibility to certain forms of schizophrenia

S Harada et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)

Article Neurosciences

Schizophrenia:: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo

KQ Do et al.

EUROPEAN JOURNAL OF NEUROSCIENCE (2000)